The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.

Autor: Nguyen, Hoang Oanh1 (AUTHOR), Salvi, Valentina1 (AUTHOR), Tiberio, Laura1 (AUTHOR), Facchinetti, Fabrizio2 (AUTHOR), Govoni, Mirco3 (AUTHOR), Villetti, Gino2 (AUTHOR), Civelli, Maurizio2 (AUTHOR), Barbazza, Ilaria1 (AUTHOR), Gaudenzi, Carolina1 (AUTHOR), Passari, Mauro1 (AUTHOR), Schioppa, Tiziana1 (AUTHOR), Sozio, Francesca1 (AUTHOR), Del Prete, Annalisa1 (AUTHOR), Sozzani, Silvano4,5 (AUTHOR) Silvano.sozzani@uniroma1.it, Bosisio, Daniela1 (AUTHOR) daniela.bosisio@unibs.it
Zdroj: Journal of Translational Medicine. 5/10/2022, Vol. 20 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje